(Q39693553)

English

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study

scientific article published on 25 October 2011

Statements

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study (English)
Richard S Finn
Carmelo Bengala
Nuhad Ibrahim
Henri Roché
Joseph Sparano
Lewis C Strauss
Justin Fairchild
Oumar Sy
Lori J Goldstein
25 October 2011
6905-6913

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit